Exercise, Sleep Quality and Nocturnal Fat Oxidation in Metabolic Syndrome

Abstract Objectives To determine if consuming four servings of white potatoes, processed potato products, or starchy carbohydrates for 16 weeks, as part of a higher protein diet, influence markers of cardiometabolic health in adults with metabolic syndrome. Methods Eleven adults with metabolic syndrome were randomly assigned to one of three higher protein diets incorporating different carbohydrate sources: 1) 4 servings of potatoes/week (P; n = 4; 4 female; 48.3 ± 9.4 y; 92.4 ± 9.6 kg; 36.3 ± 4.3 BMI); 2) processed potatoes (PP; n = 2; 1 female,1 male; 53.0 ± 15.0 y; 81.4 ± 17.0 kg; 29.6 ± 3.0 BMI); or 3) starchy carbohydrate (SC; n = 5; 4 female,1 male; 33.6 ± 5.0 y; 95.1 ± 18.2 kg; 35.3 ± 4.7 BMI). Data was collected at baseline, 4, 8,12, and 16 weeks. Glucose, cholesterol, and triglycerides were analyzed using a Cholestech LDX Analyzer. Height, weight, waist-to-hip ratio, blood pressure, mood, sleep quality, and grit were also measured. Body composition was measured using DEXA. Data were analyzed using Prism GraphPad version 8.0. Significance was set at P < 0.05. Results There were no significant changes in body weight, BMI, waist-to-hip ratio, or body composition within or between each group. However, an increase in bone mineral density was observed within all groups(P < 0.05). There was no effect of diet on plasma glucose and lipid levels. In addition, there was no change in blood pressure within each group. However, diastolic blood pressure decreased (P < 0.05) in all groups. There were no changes in mood and grit. However, sleep quality improved within all groups (P < 0.05). In addition, grip strength improved (P < 0.05) within all groups. Conclusions The preliminary results of this study indicate that incorporating white potatoes, processed potatoes, or starch carbohydrates into a higher protein diet, does not influence markers of cardiometabolic health in adults with metabolic syndrome. Higher protein diets, may improve secondary outcomes such as sleep quality, bone mineral density, and grip strength. However, a larger study population is needed. Funding Sources Alliance for Potato Research and Education.

Download Full-text

The Association between Self-Reported Sleep Quality and Metabolic Syndrome

PLoS ONE ◽

10.1371/journal.pone.0054304 ◽

2013 ◽

Vol 8 (1) ◽

pp. e54304 ◽

Cited By ~ 44

Author(s):

Hao-Chang Hung ◽

Yi-Ching Yang ◽

Horng-Yih Ou ◽

Jin-Shang Wu ◽

Feng-Hwa Lu ◽

...

Keyword(s):

Metabolic Syndrome ◽

Sleep Quality

Download Full-text

Association between sleep quality and metabolic syndrome: A systematic review and meta-analysis

Psychiatry Research ◽

10.1016/j.psychres.2019.01.096 ◽

2019 ◽

Vol 274 ◽

pp. 66-74 ◽

Cited By ~ 13

Author(s):

Ying Lian ◽

Qun Yuan ◽

Gangpu Wang ◽

Fang Tang

Keyword(s):

Systematic Review ◽

Metabolic Syndrome ◽

Sleep Quality ◽

Meta Analysis

Download Full-text

Exercise Training Adaptations in Metabolic Syndrome Individuals on Chronic Statin Treatment

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/clinem/dgz304 ◽

2019 ◽

Vol 105 (4) ◽

pp. e1695-e1704 ◽

Cited By ~ 2

Author(s):

Felix Morales-Palomo ◽

Miguel Ramirez-Jimenez ◽

Juan F Ortega ◽

Alfonso Moreno-Cabañas ◽

Ricardo Mora-Rodriguez

Keyword(s):

Metabolic Syndrome ◽

Exercise Training ◽

Fat Oxidation ◽

Time Effect ◽

Whole Body ◽

Atherogenic Dyslipidemia ◽

Control Group ◽

Training Adaptations ◽

Statin Group ◽

Statin Use

Abstract Background Statins reduce atherogenic dyslipidemia and cardiovascular disease (CVD) risk in metabolic syndrome (MetS) individuals. Exercise training could also contribute to reduce CVD by improving cardiorespiratory fitness and fat oxidation. However, statin use could interfere with training adaptations. Methods A total of 106 MetS individuals were divided into statin users (statin group, n = 46) and statin-naïve (control group, n = 60). Groups were matched by age, weight, and MetS components. Subjects completed 16 weeks of high intensity interval training (HIIT). Before and after HIIT, muscle biopsies were collected to assess mitochondrial content (citrate synthase [CS] activity) and the activity of the rate limiting β-oxidation enzyme (3-hydroxyacyl-CoA-dehydrogenase [HAD]). Fasting plasma glucose, insulin, TG, HDL-c, and LDL-c concentrations were measured. Exercise maximal fat oxidation (FOMAX) and oxygen uptake (VO2PEAK) were determined. Results Training improved MetS similarly in both groups (MetS z-score -0.26 ± 0.38 vs. -0.22 ± 0.31; P < 0.001 for time and P = 0.60 for time x group). Before training, the statin group had reduced muscle HAD activity and whole body FOMAX compared to the control group. However, 16 weeks of HIIT increased HAD and FOMAX in both groups (P < 0.03, time-effect). The statin group did not prevent the increases in CS with HIIT observed in the control group (38% vs 64%, respectively; P < 0.001, time-effect). Conversely, with training VO2PEAK improved less in the statin than in the control group (12% vs. 19%, respectively; P = 0.013, time × group effect). Conclusion Chronic statin use in MetS does not interfere with exercise training improvements in MetS components, FOMAX, or mitochondrial muscle enzymes (ie, CS and HAD). However, the statin group attenuated the improvements in VO2PEAK with training. Clinical Trial Information ClinicalTrials.gov identifier no. NCT03019796, January 13, 2017.

Download Full-text

HUBUNGAN KUALITAS TIDUR DENGAN 5 INDIKATOR SINDROMA METABOLIK PADA PERAWAT DI RUMAH SAKIT UMUM PUSAT HAJI ADAM MALIK MEDAN

VISIKES: Jurnal Kesehatan Masyarakat ◽

10.33633/visikes.v20i2.5076 ◽

2021 ◽

Vol 20 (2) ◽

Author(s):

Simon Simon

Keyword(s):

Blood Pressure ◽

Metabolic Syndrome ◽

Blood Glucose ◽

Sleep Quality ◽

Fasting Blood Glucose ◽

Hdl Cholesterol ◽

T Test ◽

Human Beings ◽

Glucose Content ◽

Significant Difference

ABSTRACTHigh death rate caused by non-transmitted diseases in the world is begun with metabolic syndrome in human beings such the increase in IMT (Body Mass Index) to be obesity, the increase in blood pressure to be hypertension, the increase in blood glucose to be diabetes mellitus, and abnormality of triglycerides, and HDL cholesterol. Many factors which trigger the indicator abnormality, and of them is bad sleep quality. The research used cross sectional design by analyzing the correlation between sleep quality and 5 metabolic syndrome indicator in female nurses in the operation room of Adam Malik Medan hospital. Sleep quality was measured by using questionnaire of Pittsburg Sleep Quality Index (PSQI), body height and weight were measured to get IMT value, blood pressure was measured by using tensimeter, blood glucose and blood lipid were measured by getting the respondent’s vena blood samples. The data were processed and analysis with independent t-test.The result with independent t-test showed that there was significant difference in IMT (sig=0,003), systolic blood pressure (sig=0,028), and fasting blood glucose content (sig=0,00). However, there was no significant difference in trigliyceride content (sig=0,519), HDL cholesterol content (sig=0,300),). The conclusion was that sleep quality was correlated with three metabolic syndrome indicators: IMT, blood pressure, and blood glucose content, but there was no correlation with trigliyceride and HDL cholesterol.Keywords: Sleep Quality, Metabolic Syndrome , T-Test,

Download Full-text

Effect of obesity and metabolic syndrome on severity, quality of life, sleep quality and inflammatory markers in patients of asthma in India

Pneumonologia i Alergologia Polska ◽

10.5603/piap.2016.0032 ◽

2016 ◽

Vol 84 (5) ◽

pp. 258-264 ◽

Cited By ~ 2

Author(s):

Mandeep Singh ◽

Nitesh Gupta ◽

Raj Kumar

Keyword(s):

Quality Of Life ◽

Metabolic Syndrome ◽

Sleep Quality ◽

Inflammatory Markers

Download Full-text

Sleep Quality of Diabetic Patients with Metabolic Syndrome, Is There A Difference?

Tropical Health and Medical Research ◽

10.35916/thmr.v0i0.19 ◽

2020 ◽

Author(s):

Savas Karatas ◽

Aysun Işıklar

Keyword(s):

Metabolic Syndrome ◽

Sleep Quality ◽

Diabetic Patients ◽

Poor Sleep ◽

Type 2 Diabetic Patients ◽

Subjective Sleep Quality ◽

Significant Difference ◽

Patients With Diabetes ◽

Type 2 Diabetic

Poor sleep quality is a prevalent health problem among patients with diabetes. Metabolic syndrome (MetS) is common in type 2 diabetic patients and associated with morbidity and mortality. We aimed to investigate sleep quality among type 2 diabetes patients according to their metabolic syndrome status. This was an analysis of data collected from 189 adult type 2 diabetic patients. The patients divided into two groups (metabolic and non-metabolic) based on the presence of MetS. Anthropometric measurements, blood pressure, and serum glucose, lipid levels were collected. The Pittsburgh Sleep Quality Index (PSQI) calculated for all patients. There was no significant difference in subjective sleep quality scores between the two groups (p > 0.05). However, there was a significant difference in sleep latency scores between the two groups; the scores of patients with MetS were lower than those of patients without MetS (p = 0.010, p < 0.05).Sleep quality was low in 57.1% (n = 108) of patients with diabetes. Poor sleep is common among diabetic patients, but in this study, metabolic syndrome existence not associated with sleep quality in type 2 diabetic patients.

Download Full-text